ZMUni Compliance Centre

In 2024, new cosmetic ingredients(NCI) continued to break new ground, becoming another major topic following the CPSR in China.

According to China’s National Medical Product Administration (NMPA), 90 NCIs were successfully notified this year, up from 69 in 2023, with 207 NCIs notified since 2021. Beyond the volume of notifications, what other developments defined China’s NCI landscape this year? What key considerations should foreign companies know when planning to register or notify NCI in China?

To support global stakeholders in understanding these developments, ZMUni Compliance Centre is hosting a webinar, "2024 Wrap-Up: China’s Cosmetic Ingredient Trends and Compliance." This session will analyze key trends, regulatory updates, and sustainability opportunities, equipping participants with insights to succeed in China’s evolving cosmetic market.

1. Opportunities in China’s Cosmetic Market: Spotlight on Ingredients
2. 2024 Regulatory Updates for Cosmetic Ingredientsin China
3. Navigating Compliance for New Cosmetic Ingredients in China
4. Looking Ahead: Sustainability and Eco-Friendly Innovations

Yolanda Yuan

Compliance Consultant at ZMUni Compliance Centre

ZMUni Compliance Centre

If you have any questions, please contact us:
+86 571-86592517
+86 18058418258
info@zmuni.com

Kindly take note that the webinar is scheduled for Jan. 23, 2025, at 21:30-22:30 Beijing Time(13:30-14:30 London Time).

*If you are unable to attend the live webinar, we still encourage you to register. We will promptly send you the webinar materials as soon as they become available.